Evidence map›Paper›PMID 40305213›Full record

ArticleBiomolecules2025

The Frequency of a Magnetic Field Reduces the Viability and Proliferation of Numerous Tumor Cell Lines.

Isabel López de Mingo, Marco Xavier Rivera González, Milagros Ramos Gómez, Ceferino Maestú Unturbe

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Isabel López de MingoEscuela Técnica Superior de Ingenieros de Telecomunicación (ETSIT), Universidad Politécnica de Madrid, 28223 Madrid, Spain.ORCID 0000-0001-9551-2241
Marco Xavier Rivera GonzálezCentro de Tecnología Biomédica (CTB), Universidad Politécnica de Madrid (UPM), Avda. Campus de Montegancedo, M40 Km38, Pozuelo de Alarcón, 28223 Madrid, Spain.ORCID 0000-0002-5996-1442
Milagros Ramos GómezEscuela Técnica Superior de Ingenieros de Telecomunicación (ETSIT), Universidad Politécnica de Madrid, 28223 Madrid, Spain.ORCID 0000-0001-5798-9508
Ceferino Maestú UnturbeCentro de Tecnología Biomédica (CTB), Universidad Politécnica de Madrid (UPM), Avda. Campus de Montegancedo, M40 Km38, Pozuelo de Alarcón, 28223 Madrid, Spain.ORCID 0000-0003-2657-9770

Funding

Fundación Humanismo y Ciencia P240060247
6 · The paper itself

Abstract

The frequency of a magnetic field has led to the development of physicochemical interaction models and to the consideration of the role of frequency as a fundamental parameter in the change of cell behavior. The main objective of this article is to find a frequency window to decrease the viability and proliferation of different tumor cell lines to compare the frequency response of each. For this purpose, tumor cell lines PC12 (rat), B16F10 (mouse), SKBR3 (human), MDA-MB-231 (human), and the non-tumor cell line 3T3 (mouse) are exposed to a magnetic field of 100 µT for 24, 48, and 72 hours in frequency windows contained in the range [20-100] Hz, and their viability and proliferation behavior is evaluated. The results show a frequency-, exposure-time-, and cell-line-dependent behavior, with the most pronounced changes for most cell lines at frequencies of 45, 50, and 55 Hz. It is concluded that each cell type could respond to specific frequency codes that allow the modification of its behavior in vital cellular processes related to tumor development. Knowledge of these codes would allow for the therapeutic application of magnetic fields in oncological pathologies.

Indexed as

Cell ProliferationMagnetic FieldsNeoplasmsAnimalsCell Line, TumorCell SurvivalHumansMicePC12 CellsRatsELF-EMFsfrequencymagnetic fieldproliferationtumor cellsviability

Identifiers

PMID40305213
PMCPMC12024963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.